HalozymeTherapeutics HALO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSIHalozyme Therapeutics HALO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange
operates under Health Care sector & deals in Biotechnology Biological Products No Diagnostic Substances
Daily price and charts and targets HalozymeTherapeutics Strong Daily Stock price targets for HalozymeTherapeutics HALO are 60.91 and 62.36 | Daily Target 1 | 59.85 | | Daily Target 2 | 60.52 | | Daily Target 3 | 61.3 | | Daily Target 4 | 61.97 | | Daily Target 5 | 62.75 |
Daily price and volume Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
| Fri 02 May 2025 |
61.19 (1.93%) |
61.10 |
60.63 - 62.08 |
1.0358 times |
| Thu 01 May 2025 |
60.03 (-2.26%) |
61.00 |
59.57 - 61.63 |
1.0752 times |
| Wed 30 April 2025 |
61.42 (0.99%) |
60.97 |
59.77 - 61.80 |
1.2883 times |
| Tue 29 April 2025 |
60.82 (0.41%) |
60.11 |
59.53 - 61.85 |
1.0825 times |
| Mon 28 April 2025 |
60.57 (0.13%) |
60.41 |
59.92 - 61.47 |
0.8369 times |
| Fri 25 April 2025 |
60.49 (2.09%) |
59.02 |
58.49 - 60.90 |
0.9363 times |
| Thu 24 April 2025 |
59.25 (1.79%) |
58.46 |
57.65 - 59.39 |
1.18 times |
| Tue 22 April 2025 |
58.21 (1.61%) |
58.00 |
57.40 - 58.44 |
0 times |
| Mon 21 April 2025 |
57.29 (-2.55%) |
58.74 |
56.47 - 58.99 |
1.1949 times |
| Thu 17 April 2025 |
58.79 (-0.05%) |
58.18 |
57.58 - 59.33 |
1.3701 times |
| Wed 16 April 2025 |
58.82 (0%) |
61.17 |
57.50 - 61.30 |
0 times |
Weekly price and charts HalozymeTherapeutics Strong weekly Stock price targets for HalozymeTherapeutics HALO are 60.36 and 62.91 | Weekly Target 1 | 58.38 | | Weekly Target 2 | 59.79 | | Weekly Target 3 | 60.933333333333 | | Weekly Target 4 | 62.34 | | Weekly Target 5 | 63.48 |
Weekly price and volumes for Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
| Fri 02 May 2025 |
61.19 (1.16%) |
60.41 |
59.53 - 62.08 |
1.4491 times |
| Fri 25 April 2025 |
60.49 (2.89%) |
58.74 |
56.47 - 60.90 |
0.9022 times |
| Thu 17 April 2025 |
58.79 (-0.05%) |
61.17 |
57.50 - 61.30 |
0.3733 times |
| Wed 16 April 2025 |
58.82 (0%) |
61.17 |
57.50 - 61.30 |
0 times |
| Wed 16 April 2025 |
58.82 (0%) |
61.17 |
57.50 - 61.30 |
0.4386 times |
| Wed 16 April 2025 |
58.82 (0%) |
61.17 |
57.50 - 61.30 |
0 times |
| Wed 16 April 2025 |
58.82 (-2.32%) |
61.30 |
57.50 - 62.14 |
0.7445 times |
| Fri 11 April 2025 |
60.22 (0.75%) |
57.50 |
55.71 - 61.81 |
2.559 times |
| Fri 04 April 2025 |
59.77 (-6.38%) |
63.39 |
59.11 - 64.17 |
2.2614 times |
| Fri 28 March 2025 |
63.84 (-2.03%) |
65.69 |
62.72 - 66.00 |
1.2719 times |
| Fri 21 March 2025 |
65.16 (4.64%) |
62.46 |
60.92 - 65.21 |
2.5238 times |
Monthly price and charts HalozymeTherapeutics Strong monthly Stock price targets for HalozymeTherapeutics HALO are 60.38 and 62.89 | Monthly Target 1 | 58.44 | | Monthly Target 2 | 59.81 | | Monthly Target 3 | 60.946666666667 | | Monthly Target 4 | 62.32 | | Monthly Target 5 | 63.46 |
Monthly price and volumes Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
| Fri 02 May 2025 |
61.19 (-0.37%) |
61.00 |
59.57 - 62.08 |
0.0819 times |
| Wed 30 April 2025 |
61.42 (-3.75%) |
64.06 |
55.71 - 64.17 |
1.1008 times |
| Mon 31 March 2025 |
63.81 (7.88%) |
59.14 |
56.90 - 66.00 |
1.139 times |
| Fri 28 February 2025 |
59.15 (4.43%) |
55.12 |
54.96 - 60.67 |
0.8172 times |
| Fri 31 January 2025 |
56.64 (18.47%) |
48.23 |
47.52 - 57.46 |
1.1569 times |
| Tue 31 December 2024 |
47.81 (0.04%) |
48.20 |
46.39 - 49.79 |
0.773 times |
| Tue 26 November 2024 |
47.79 (-5.5%) |
55.66 |
42.01 - 62.13 |
1.7425 times |
| Thu 31 October 2024 |
50.57 (-11.65%) |
56.97 |
48.84 - 62.00 |
1.1255 times |
| Mon 30 September 2024 |
57.24 (-10.35%) |
63.59 |
55.43 - 64.18 |
0.9697 times |
| Fri 30 August 2024 |
63.85 (15.54%) |
55.52 |
51.46 - 65.53 |
1.0935 times |
| Wed 31 July 2024 |
55.26 (5.54%) |
52.23 |
50.68 - 57.09 |
1.0099 times |
DMA SMA EMA moving averages of Halozyme Therapeutics HALO
DMA (daily moving average) of Halozyme Therapeutics HALO
| DMA period | DMA value | | 5 day DMA | 60.81 | | 12 day DMA | 59.64 | | 20 day DMA | 59.67 | | 35 day DMA | 60.9 | | 50 day DMA | 60.54 | | 100 day DMA | 56.89 | | 150 day DMA | 55.69 | | 200 day DMA | 56.37 | EMA (exponential moving average) of Halozyme Therapeutics HALO
| EMA period | EMA current | EMA prev | EMA prev2 | | 5 day EMA | 60.64 | 60.36 | 60.52 | | 12 day EMA | 60.16 | 59.97 | 59.96 | | 20 day EMA | 60.1 | 59.98 | 59.97 | | 35 day EMA | 60.06 | 59.99 | 59.99 | | 50 day EMA | 60.34 | 60.31 | 60.32 |
SMA (simple moving average) of Halozyme Therapeutics HALO
| SMA period | SMA current | SMA prev | SMA prev2 | | 5 day SMA | 60.81 | 60.67 | 60.51 | | 12 day SMA | 59.64 | 59.44 | 59.34 | | 20 day SMA | 59.67 | 59.49 | 59.45 | | 35 day SMA | 60.9 | 60.93 | 60.96 | | 50 day SMA | 60.54 | 60.47 | 60.41 | | 100 day SMA | 56.89 | 56.77 | 56.66 | | 150 day SMA | 55.69 | 55.68 | 55.68 | | 200 day SMA | 56.37 | 56.33 | 56.29 |
|
|
